Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
04/08/1999 | WO1999017112A1 Apparatus and method for determining the air entrainment characteristics of liquids |
04/08/1999 | WO1999017110A1 Combustible gas sensor with integral hydrogen generator |
04/08/1999 | WO1999017095A1 Biosensor |
04/08/1999 | WO1999017094A2 Consumable for laser capture microdissection |
04/08/1999 | WO1999016909A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
04/08/1999 | WO1999016907A2 Reagent and method for attaching target molecules to a surface |
04/08/1999 | WO1999016903A1 Method for screening heat shock protein expression induction regulators |
04/08/1999 | WO1999016894A1 Method for determining active agents |
04/08/1999 | WO1999016888A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
04/08/1999 | WO1999016887A2 Compositions and methods for identifying pkb kinase inhibitors |
04/08/1999 | WO1999016882A1 LMB GENE OF $i(STREPTOCOCCUS AGALACTIAE) |
04/08/1999 | WO1999016881A1 Antigen protein and nucleic acid coding for said protein |
04/08/1999 | WO1999016880A2 Protein involved in abscisic acid signalling |
04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
04/08/1999 | WO1999016875A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
04/08/1999 | WO1999016873A1 Anticalins |
04/08/1999 | WO1999016867A1 Transgenic model comprising tcr alpha and beta chains |
04/08/1999 | WO1999016861A1 Gram negative coccoid bacterium |
04/08/1999 | WO1999016832A1 Aromatic-substituted xanthene dyes |
04/08/1999 | WO1999016790A1 Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis |
04/08/1999 | WO1999016789A1 Apoptosis-related compounds and their use |
04/08/1999 | WO1999016784A1 Ras-binding protein (pre1) |
04/08/1999 | WO1999016781A2 Automatable method for preparing samples which can be universally applied |
04/08/1999 | WO1999016526A1 Method for separating complex mixtures by means of solid phase extraction for use in active substance search and analysis |
04/08/1999 | WO1999016469A1 Altered dna synthesome components as biomarkers for malignancy |
04/08/1999 | WO1999016357A1 Method for optimising prognoses, diagnostics and therapies |
04/08/1999 | WO1999016353A1 Spectral bio-imaging of the eye |
04/08/1999 | WO1999016319A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
04/08/1999 | WO1999006549A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
04/08/1999 | WO1999005521A3 Conjugate for differentiating between healthy and unhealthy tissue |
04/08/1999 | WO1999005504A3 Flow cytometry nozzle for high efficiency cell sorting |
04/08/1999 | WO1999005269A3 Transcriptional silencer protein nrf |
04/08/1999 | WO1999004239A3 Magnetic pin for concentrating and separating particles |
04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
04/08/1999 | WO1999003823A3 Novel polyamine analogues as therapeutic and diagnostic agents |
04/08/1999 | WO1998058053A9 Human receptor tyrosine kinase, kdr |
04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
04/08/1999 | WO1998026644A9 Confirmatory assays for small molecule drugs |
04/08/1999 | DE19842953A1 Automatic analysis apparatus |
04/08/1999 | DE19747572C1 Apparatus for fluorescence immunoassay |
04/08/1999 | DE19742261A1 Alcohol safety system e.g. for vehicle driver |
04/08/1999 | DE19741892A1 Monitoring level and quality of e.g. hygroscopic brake fluid or motor oil with special reference to its boiling point |
04/08/1999 | DE19741287A1 Determination of reduced anticoagulatory response to tissue factor pathway inhibitor (TFPI) |
04/08/1999 | CA2305809A1 Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis |
04/08/1999 | CA2305781A1 Nucleic acids coding for proteins capable of interacting with presenilins |
04/08/1999 | CA2305714A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
04/08/1999 | CA2305686A1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
04/08/1999 | CA2305681A1 Apoptosis-related compounds and their use |
04/08/1999 | CA2305678A1 Protein involved in abscisic acid signalling |
04/08/1999 | CA2305625A1 Altered dna synthesome components as biomarkers for malignancy |
04/08/1999 | CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
04/08/1999 | CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists |
04/08/1999 | CA2304763A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
04/08/1999 | CA2304555A1 A method of determining the presence of volume dependent hypertension and related apparatus |
04/08/1999 | CA2304484A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
04/08/1999 | CA2304209A1 Ras-binding protein (pre1) |
04/08/1999 | CA2298854A1 Compositions and methods for identifying pkb kinase inhibitors |
04/08/1999 | CA2273081A1 Method for screening heat shock protein expression induction regulators |
04/08/1999 | CA2245937A1 Novel histidine kinase |
04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
04/08/1999 | CA2213680A1 Nucleotide sequences and protein sequences |
04/08/1999 | CA2212606A1 A target for pre-symptomatic detection, control and prevention of multiple sclerosis in humans |
04/07/1999 | EP0907083A1 Automatic handling of sample cups closed with a screwable cap |
04/07/1999 | EP0907082A2 Method of detecting a substance using enzymatically-induced decomposition of dioxetanes |
04/07/1999 | EP0907081A1 Total protein detection method |
04/07/1999 | EP0907080A1 Method for assaying antigen relating to mental stress disorders |
04/07/1999 | EP0907079A1 Quality control apparatus for textured filament yarn |
04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
04/07/1999 | EP0906958A2 Staphylococcus peptidyl-tRNA hydrolase (Pth) |
04/07/1999 | EP0906957A2 Lgt polypeptide |
04/07/1999 | EP0906956A2 MurD from Streptococcus pneumoniae |
04/07/1999 | EP0906955A2 FtsY |
04/07/1999 | EP0906954A1 Amino-terminal truncated c-c chemokines as chemokine antagonist |
04/07/1999 | EP0906577A1 Screening compounds for the ability to alter the production of amyloid-beta peptide |
04/07/1999 | EP0906576A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
04/07/1999 | EP0906575A1 Marker for male infertility and/or fertility |
04/07/1999 | EP0906574A1 Methods and kits for the detection of endotoxin |
04/07/1999 | EP0906573A1 Methods of diagnosing clinical subtypes of crohn's disease |
04/07/1999 | EP0906572A1 Masking background fluorescence and luminescence in optical analysis of biomedical assays |
04/07/1999 | EP0906571A1 Labelling and selection of molecules |
04/07/1999 | EP0906570A1 Process to eliminate haemoglobin errors when analysing medical samples |
04/07/1999 | EP0906569A1 Process for the analysis of medical samples containing haemoglobin |
04/07/1999 | EP0906568A1 Specimen collection fluid |
04/07/1999 | EP0906567A1 Process to eliminate haemoglobin errors during the determination of albumin |
04/07/1999 | EP0906566A1 OPTICAL SENSOR SYSTEM FOR pH DETERMINATION INDEPENDENTLY OF THE ION STRENGTH USING FLUORESCEIN BOUND TO A POLYMER VIA A URETHANE AND/OR UREA GROUP |
04/07/1999 | EP0906562A2 Detection of ligand interaction with polymeric material |
04/07/1999 | EP0906560A1 Method and arrangement for nondestructive classification |
04/07/1999 | EP0906449A2 System and method for carrying out and monitoring biological processes |
04/07/1999 | EP0906448A1 Methods for the diagnosis and prognosis of cancer |
04/07/1999 | EP0906447A1 Methods and devices for determination of an analyte in body fluid |
04/07/1999 | EP0906433A1 Protein tyrosine phosphatases of hematopoietic cells |
04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
04/07/1999 | EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr] |
04/07/1999 | EP0906423A1 Metastasis-associated antigen and antibodies thereto |
04/07/1999 | EP0906422A1 Human cell death-associated protein |
04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
04/07/1999 | EP0906417A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
04/07/1999 | EP0906337A2 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF |